Mona M. Shangold — Endo Lab

rct 1999

A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding

American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(99)70147-x

OBJECTIVE: The objective of this study was to evaluate the safety and efficacy of 2 doses of a transvaginal polycarbophil-based progesterone gel (4% and 8%) in hormone replacement therapy. STUDY DESIGN: This multicenter, randomized, parall…

rct 1991

Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea

·doi:10.1016/s0015-0282(16)54714-1

ObjectiveTo compare two dosages of oral micronized progesterone (P) and placebo for withdrawal bleeding and side effects.DesignProspective, randomized, double-blind.SettingAcademic institution.ParticipantsOut of 190 screened with oligomenor…

other 1984

Menstrual disturbances in the athlete

Primary care ·doi:10.1016/s0095-4543(21)01171-4

Women should be encouraged to exercise. Those who develop menstrual problems should be thoroughly evaluated to detect any serious causes and should be treated to prevent any serious results. The importance of exercise in the lifestyle of fe…

other 1976

Plasma prostaglandin F 2-alpha levels in dysmenorrehic women

Fertility and sterility ·doi:10.1016/s0015-0282(16)42135-7

Plasma prostaglandin F 2-alpha (PGF 2-alpha) concentrations were compared in nine ovulatory dysmenorrheic women, one dysmenorrheic oral contraceptive user, and two nondysmenorrheic control subjects, in an effort to demonstrate a relationshi…